Metraipolis › archive › dc_6ef1752d2f08

Pan-cancer profiles of mesothelin (MSLN) unveil diagnostic potential and therapeutic targetability of pancreatic adenocarcinoma — Europe PMC PMID:42623414

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42623414
DOI
10.1371/journal.pone.0354334
License (as archived)
solo-consultazione
Archived
2026-10-08T10:12:13.779Z
SHA-256 of the archived text
bb82f2818d9067eaf7aee5a27158e9388153f76f66b6bc1de2b485ce530cf277
Stable URL of this page
https://metraipolis.com/documento/dc_6ef1752d2f08

How to cite

Pan-cancer profiles of mesothelin (MSLN) unveil diagnostic potential and therapeutic targetability of pancreatic adenocarcinoma — Europe PMC PMID:42623414 — Europe PMC (en), https://europepmc.org/article/MED/42623414 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ef1752d2f08 (Metraipolis archive dc_6ef1752d2f08, sha256 bb82f2818d9067eaf7aee5a27158e9388153f76f66b6bc1de2b485ce530cf277)
BibTeX
@misc{dc6ef1752d2f08,
  title = {Pan-cancer profiles of mesothelin (MSLN) unveil diagnostic potential and therapeutic targetability of pancreatic adenocarcinoma — Europe PMC PMID:42623414},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42623414},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ef1752d2f08; sha256 bb82f2818d9067eaf7aee5a27158e9388153f76f66b6bc1de2b485ce530cf277},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42623414. Agents can read the archived copy with the MCP tool read_document.